| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Bradley Saenger is Chief Financial Officer at TNXP. Bradley Saenger's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $11K at current prices.
Net of sales, the TNXP filings show accumulation of 300 shares.
Bradley Saenger has 14 Form 4 filings on record from March 2017 to June 2026, all as Chief Financial Officer at Tonix Pharmaceuticals (TNXP), 2017–2026.
The 29 reported transactions were 26 option or other derivative awards, 2 other transactions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $1K and no sales.
The only open-market purchase was 300 shares of TNXP at an average $4.10 on June 14, 2018, about $1K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 14, 2018 | TNXP Tonix Pharmaceuticals Holding Corp. | Chief Financial Officer | Buy | 300 | $4.10 | $1,230.00 | +10.8% |